The future of genomic medicine in cancer is promising. Advances in artificial intelligence and machine learning are expected to enhance the analysis of genomic data, leading to more precise and timely decisions. Efforts to reduce costs and improve accessibility are ongoing, with the goal of making personalized cancer care available to a broader population. Additionally, ongoing research into gene therapy and immunotherapy holds potential for groundbreaking treatments that could revolutionize cancer care.
